C
Christopher S. Pepin
Researcher at University of Maryland, Baltimore
Publications - 3
Citations - 442
Christopher S. Pepin is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Genotype & Retrospective cohort study. The author has an hindex of 3, co-authored 3 publications receiving 398 citations. Previous affiliations of Christopher S. Pepin include Howard Hughes Medical Institute & University of Vermont.
Papers
More filters
Journal ArticleDOI
Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia
Shannon Takala-Harrison,Christopher G Jacob,Cesar Arze,Michael P. Cummings,Joana C. Silva,Arjen M. Dondorp,Mark M. Fukuda,Tran Tinh Hien,Mayfong Mayxay,Mayfong Mayxay,Mayfong Mayxay,Harald Noedl,François Nosten,Myat Phone Kyaw,Nguyen Thanh Thuy Nhien,Mallika Imwong,Delia Bethell,Youry Se,Chanthap Lon,Stuart D. Tyner,David L. Saunders,Frédéric Ariey,Odile Mercereau-Puijalon,Didier Menard,Paul N. Newton,Paul N. Newton,Maniphone Khanthavong,Bouasy Hongvanthong,Peter Starzengruber,Hans-Peter Fuehrer,Paul Swoboda,Wasif A. Khan,Aung Pyae Phyo,Myaing Myaing Nyunt,Myat Htut Nyunt,Tyler S. Brown,Matthew Adams,Christopher S. Pepin,Jason A. Bailey,John C. Tan,Michael T. Ferdig,Taane G. Clark,Olivo Miotto,Bronwyn MacInnis,Dominic P. Kwiatkowski,Nicholas J. White,Pascal Ringwald,Christopher V. Plowe +47 more
TL;DR: While there was some evidence of spreading resistance, there was no evidence of resistance moving westward from Cambodia into Myanmar, and K13 appears to be a major determinant of artemisinin resistance throughout Southeast Asia.
Journal ArticleDOI
Risk factors for Central Line-associated Bloodstream Infections: A Focus on Comorbid Conditions
Christopher S. Pepin,Kerri A. Thom,John D. Sorkin,Surbhi Leekha,Max Masnick,Michael Anne Preas,Lisa Pineles,Anthony D. Harris +7 more
TL;DR: The study supports the need for additional research into risk factors for CLABSI, including electronically available comorbid conditions, by exploring risk factors using the Charlson Comorbidity Index and the Chronic Disease Score.
Journal ArticleDOI
Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation.
TL;DR: Almost a quarter to a third of pregnant women enrolled in clinical trials for smoking cessation were determined to be using illicit drugs, with marijuana use being the most prevalent.